Everfront Biotech wins Grand Prize at PharmaEssentia Innovation Award
The award recognizes outstanding teams in hematology, oncology, immunology, and rare diseases.
Latest Everfront Biotech News & Updates
See the latest news and media coverage for EFB. We track all announcements, press releases, and industry mentions in real time, all in one place.
Last updated
Latest news about Everfront Biotech (EFB)
In short: EFB won the PharmaEssentia Innovation Award Grand Prize and advanced clinical trials for its glioblastoma treatment, Cerebraca Wafer.
Company announcements
EFB announces clinical results for Cerebraca® Wafer at ASCO 2026
The wafer showed potential to reverse chemoresistance and a Phase IIb/III trial has started.
Everfront Biotech presents updated Cerebraca Wafer results at SNO 2025
The e-poster covers Phase I/IIa trial data for Recurrent Glioblastoma treatment and Phase IIb/III plans. No drug-related adverse effects reported.
Everfront Biotech presents Cerebraca® Wafer trial results at CNS meeting
Phase I/IIa trial shows 15.7 months median survival, no serious adverse events. Plans global Phase IIb trial launch late 2025.
Media coverage
Everfront Biotech Files for Proposed IPO
Everfront Biotech (EFB) has filed for a proposed IPO. The company describes itself as: "We are a clinical stage biopharmaceutical company dedicated to the discovery...
Never miss news about EFB
Track EFB and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
VTX
AITX
Amrize
Advocate Health
Arconic
ARDG
Ashland
LB Pharmaceuticals
Gossamer Bio
USAR
Simpson Strong‑Tie
Celestica
Capricor
MediaAlpha
3D Systems
Generate:Biomedicines
FutureFuel
WisdomTree
Celeris
Coupang
LiveWire
Fermi
Science
Biglari Holdings Inc.
Pega
Global Self Storage
Utz
Humanoid
Diverzify
Openship
Taalas
Calico
Recursion
Hey API